Abdelnour-Berchtold Etienne, Perentes Jean Yannis, Ris Hans-Beat, Beigelman Catherine, Lovis Alban, Peters Solange, Krueger Thorsten, Gonzalez Michel
World J Surg. 2016 Feb;40(2):373-9. doi: 10.1007/s00268-015-3254-7.
Pulmonary metastasectomy is increasingly performed in selected patients by video-assisted thoracic surgery (VATS) on the base of thin-slice high-resolution CT-Scan (HRCT). This study determines the overall survival and ipsilateral recurrence rate and of patients undergoing after VATS lung metastasectomy.
Retrospective single institution study of all patients who underwent VATS pulmonary metastasectomy on the base of HRCT with curative intent between 2005 and 2014.
Seventy-seven patients (41 males, 36 females) underwent VATS pulmonary metastasectomy for solitary (n = 63) or multiple (n = 14) lung metastases in the context of colorectal carcinoma (n = 26), sarcoma (n = 17), melanoma (n = 16), or other primaries (n = 18). Nine patients had bilateral lung metastases and underwent synchronous (n = 4) or sequential (n = 5) VATS resections. Preoperative CT-guided hook wire localization of the lesions was performed in 65 patients (84 %). The postoperative mortality and morbidity rates were 0 and 5.2 %, respectively. During a mean follow-up time of 24 months (range 1–120 months), tumor progression occurred in 46 patients. Twenty-three patients (30 %) had pulmonary recurrence only, of them, eight patients (10 %) in the operated lungs. Seven of eight patients with recurrence in the operated lungs underwent a second metastasectomy by VATS (n = 5) or thoracotomy (n = 2). The overall 5-year survival rate was 54 % and without difference between patients without tumor recurrence and those with pulmonary recurrence treated by re-metastasectomy.
Ipsilateral recurrence remains low after VATS pulmonary metastasectomy guided by preoperative HRCT and can be efficiently treated by re-metastasectomy.
在薄层高分辨率CT扫描(HRCT)的基础上,越来越多的特定患者通过电视辅助胸腔镜手术(VATS)进行肺转移瘤切除术。本研究确定了接受VATS肺转移瘤切除术后患者的总生存率和同侧复发率。
对2005年至2014年间所有基于HRCT以治愈为目的接受VATS肺转移瘤切除术的患者进行单机构回顾性研究。
77例患者(41例男性,36例女性)因结直肠癌(n = 26)、肉瘤(n = 17)、黑色素瘤(n = 16)或其他原发肿瘤(n = 18)发生的孤立性(n = 63)或多发性(n = 14)肺转移而接受VATS肺转移瘤切除术。9例患者有双侧肺转移,接受了同期(n = 4)或序贯(n = 5)VATS切除术。65例患者(84%)术前行CT引导下病变钩丝定位。术后死亡率和发病率分别为0和5.2%。在平均24个月(范围1 - 120个月)的随访期内,46例患者出现肿瘤进展。23例患者(30%)仅出现肺部复发,其中8例患者(10%)在手术肺内复发。8例手术肺内复发患者中的7例接受了第二次VATS(n = 5)或开胸手术(n = 2)的转移瘤切除术。总体5年生存率为54%,无肿瘤复发患者与接受再次转移瘤切除术治疗的肺部复发患者之间无差异。
术前HRCT引导下的VATS肺转移瘤切除术后同侧复发率仍然较低,再次转移瘤切除术可有效治疗。